Evidence map›Paper›PMID 23396358›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2013

Non-small cell lung cancer evaluated with quantitative contrast-enhanced CT and PET-CT: net enhancement and standardized uptake values are related to tumour size and histology.

Luca Brunese, Barbara Greco, Francesca Rosa Setola, Francesco Lassandro, Mario Rosario Guarracino, Marialiusa De Rimini, Sergio Piccolo, Nicolina De Rosa, Roberto Muto, Andrea Bianco and 3 more

Abstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Patients with single brain metastasis from non-small cell lung cancer equally benefit from stereotactic radiosurgery and surgery: a systematic review.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. A review on advances inInsights into imaging · 2022
    Review
  10. Article
  11. Texture Analysis on [Molecular imaging and biology · 2019
    Article
  12. Article
  13. Radiofrequency ablation of osteoid osteoma.Acta bio-medica : Atenei Parmensis · 2018
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Rs3842530 Polymorphism in MicroRNA-205 Host Gene in Lung and Breast Cancer Patients.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Luca BruneseDepartment of Medicine and Health Sciences, Università del Molise, Contrada Tappino, Campobasso, Italy. lucabrunese@libero.it
Barbara Greco
Francesca Rosa Setola
Francesco Lassandro
Mario Rosario Guarracino
Marialiusa De Rimini
Sergio Piccolo
Nicolina De Rosa
Roberto Muto
Andrea Bianco
Pietro Muto
Roberto Grassi
Antonio Rotondo

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPersonalized cancer therapy remains a challenge. In this context, we attempted to identify correlations between tumour angiogenesis, tumour metabolism and tumour cell type. To this aim, we used single=phase multidetector computed tomography (MDCT) and hybrid positron emission tomography-computed tomography (PET/CT) to determine whether net enhancement and standardized uptake value (SUVmax) were correlated with tumour size and cytology in patients affected by non-small cell lung cancer (NSCLC). MATERIAL AND

methodsOur study included 38 patients (30 men, 8 women, mean age 70) with a NSCLC measuring between 3 cm and 7 cm, using a 16-slice multidetector CT (Brilliance Philips) and with PET-CT (Biograph 16 Siemens Medical Solutions). The following lesion parameters were evaluated: maximum diameter, medium density before contrast injection (CTpre), medium density after contrast injection (CTpost average), density in the most enhanced part of the lesion after contrast (CTpost max), net enhancement, SUVmax, age, and cytology. Correlation coefficient and p-value were computed for each pair of variables. In addition, correlations were computed for each pair of variables, and for all combinations of tumour types. We focused on subsets of data with more than 10 observations, and with correlation r>0.500 and p<0.05.

resultsA weak correlation (r=0.32; p=0.048) was found between SUVmax and tumour size; the correlation was stronger for masses larger than 31 mm (r=0.4515; p=0.0268). No other correlations were found among the variables examined.

conclusionsOur data may have prognostic significance, and could lead to more appropriate surgical treatment and better treatment outcome.

Indexed as

Multimodal ImagingPositron-Emission TomographyTomography, X-Ray ComputedTumor BurdenAdenocarcinomaAgedCarcinoma, Non-Small-Cell LungContrast MediaFemaleFluorodeoxyglucose F18HumansLung NeoplasmsMaleContrast MediaFluorodeoxyglucose F18

Identifiers

PMID23396358
PMCPMC3628799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.